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detail how three selected ferritins oxidise Fe2+ to explore 
the mechanistic variations that exist amongst ferritins. We 
suggest that the mechanistic differences reflect differing 
evolutionary pressures on amino acid sequences, and that 
these differing pressures are a consequence of different pri-
mary functions for different ferritins.
Keywords Bacterioferritin · Ferritin · Ferroxidase · Iron 
oxidation · Iron storage
Abbreviations
BFR  Bacterioferitin
EM  Electron microscopy
EPR  Electron paramagnetic resonance spectroscopy
FTN  Prokaryotic ferritin
Introduction
Ferritins are characterized by their ability to accumulate 
large deposits of non-heme iron. Laufberger [1] coined the 
name ferritin in 1937, from the Latin ferratus (meaning 
furnished, covered or shod with iron [2]), to describe the 
iron-rich protein he had crystallized. Now the name ferritin 
is used to describe a superfamily of proteins as well as the 
specific type of protein exemplified by animal ferritins [3–
10]. Most members of the ferritin superfamily consist of 24 
subunits arranged to form an approximately spherical pro-
tein shell into which non-heme iron is deposited (Fig. 1). 
A single ferritin molecule of this type can hold up to 4300 
iron ions in its central cavity [3, 11]. In addition to the 
24-mer ferritins, so-called mini-ferritins composed of 12 
subunits have been discovered in bacteria that can accom-
modate much smaller amounts of iron in their smaller cen-
tral cavities [6]. Almost from the first description of ferritin 
Abstract Ferritins are a superfamily of iron oxidation, 
storage and mineralization proteins found throughout the 
animal, plant, and microbial kingdoms. The majority of 
ferritins consist of 24 subunits that individually fold into 
4-α-helix bundles and assemble in a highly symmetric man-
ner to form an approximately spherical protein coat around 
a central cavity into which an iron-containing mineral can 
be formed. Channels through the coat at inter-subunit con-
tact points facilitate passage of iron ions to and from the 
central cavity, and intrasubunit catalytic sites, called fer-
roxidase centers, drive Fe2+ oxidation and O2 reduction. 
Though the different members of the superfamily share a 
common structure, there is often little amino acid sequence 
identity between them. Even where there is a high degree 
of sequence identity between two ferritins there can be 
major differences in how the proteins handle iron. In this 
review we describe some of the important structural fea-
tures of ferritins and their mineralized iron cores, consider 
how iron might be released from ferritins, and examine in 
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up to the present time, the mechanism(s) by which such 
proteins accumulate iron has been intensively studied and 
yet despite the huge volume of work reported a full descrip-
tion of how any ferritin operates has not yet been achieved. 
The original publication by Granick and Michaelis in 1943 
on the preparation of apo-ferritin [12], protein in which the 
non-heme iron has been removed, established that simple 
procedures with Fe3+ salts failed to reconstitute holofer-
ritin, the iron mineral-containing form, and since then a 
variety of in vitro methods for preparing holoferritin have 
been described. However, as with much of the literature on 
the mechanism(s) of ferritin activity, it is not clear that any 
of the described procedures mimic exactly physiologically 
relevant mechanisms. In large part this lack of clarity stems 
from the complex chemistry of one of the ferritin sub-
strates, iron. Fe3+ ions are poorly soluble in aqueous solu-
tions and Fe2+ ions are susceptible to oxidation in aerobic 
environments. Presumably, this complex chemistry is the 
reason ferritins exist; it is important for biological organ-
isms to sequester excess iron in a manner that does not lead 
to insoluble aggregates of Fe3+ ions interfering with their 
normal biochemistry. Putting the iron into a protein shell 
is an elegant solution. This review discusses how selected 
24mer ferritins accumulate iron in vitro. The chosen pro-
teins have been selected either with a view to exploring 
their physiological roles, and where possible we highlight 
the connections between these and the in vitro data, or 
because they illustrate a striking difference in behavior to 
related proteins despite similar structures.
24-mer ferritins share a common structure (Fig. 1): a 
protein shell assembled from 24 4-α-helical bundle subunits 
surrounding an internal cavity of ~80 Å diameter; channels 
through the protein coat that connects the inner cavity with 
the protein’s external environment; and catalytic sites that 
promote the oxidation of Fe2+ to Fe3+. There are major 
differences as well, most notably that the bacterioferritin 
(BFR) family of proteins contains up to 12 b–type heme 
groups at intersubunit sites, while the other 24mer ferri-
tins are heme-free [5, 13, 14]. There are also differences 
in the number and types of channels through the shell. All 
24mer ferritins have channels at the threefold and fourfold 
symmetry axes, but BFRs and heme-free prokaryotic fer-
ritins (FTNs) also have an additional set of B-channels [15] 
which are not aligned with an axis of symmetry and occur 
where three subunits interact (Fig. 2).
The nature of the catalytic sites for Fe2+ oxidation, 
known as the ferroxidase centers and located in the mid-
dle of each subunit, is different as well [9, 17–25]. Though 
ferroxidase centers were first identified in human ferritin 
and BFR more than 20 years ago, the differences in their 
properties has meant that even today it is doubtful that all 
the key structural influences on the centers have been iden-
tified. This is an important point because these differences 
go to the heart of different interpretations of mechanistic 
data. Later we shall describe in detail the ferroxidase cent-
ers of our selected ferritins to illustrate this. Despite the 
high degree of structural similarity between ferritins, there 
is relatively little amino acid sequence identity between 
some members of the family, for example, BFR and FTN, 
beyond conservation of many of the residues forming the 
ferroxidase centers [7].
At a time when so many of the reported studies on fer-
ritins involve the use of proteins prepared by recombinant 
methods, it is relevant to note that it is not only the pro-
tein shells of ferritins that differ, but also the nature of the 
iron cores they have accumulated in their central cavities. 
Generally, recombinant ferritins are isolated with relatively 
little iron content whereas native ferritins are often heav-
ily iron-loaded, with the majority of the iron contained in 
a mineralized form. Native animal ferritins are generally 
reported to contain Fe3+ poly-oxo-hydroxide cores that are 
highly crystalline while plant ferritins and BFRs usually 
have phosphate-rich Fe3+ cores with an amorphous mor-
phology. We return to this topic later.
Fig. 1  Overall structure of 
24meric ferritins. Left, view 
down one of six fourfold chan-
nels through the protein coat. 
The locations of four of the 24 
B-channels are indicated by ‘B’. 
Right, view down one of eight 
threefold channels. Generated 
using PyMol with PDB file 
1BCF
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In vitro mechanistic studies on the uptake of iron by 
ferritins has concentrated almost exclusively on the reac-
tion of ferritins with added Fe2+ ions in the presence of an 
oxidant, most usually O2. In the absence of a ferritin the 
aerobic oxidation of Fe2+ below pH ~7 is rather slow. Fer-
ritins catalyze oxidation of Fe2+ by O2 but to do so the Fe
2+ 
ions have to enter the protein shell where the Fe3+ ions pro-
duced are trapped within the protein. There are many ques-
tions that need to be considered to describe this process, 
including:
1. How does Fe2+ enter the protein shell?
2. Where does the Fe2+ get oxidized?
3. How does the cavity accumulate Fe3+?
These are overarching questions and, as we shall see, 
some of the issues at the forefront of ferritin research con-
cern detailed chemical questions. For example, at least 
some of the Fe2+ gets oxidised at ferroxidase centers and 
how the di-iron site is formed and whether it breaks down 
following Fe2+ oxidation are major concerns (see, for 
example, [9, 26–28]). A current issue in ferritin research 
is whether there is a universal mechanism that accounts 
for core formation resulting from the aerobic oxidation 
of Fe2+, as Hagen and his colleagues have proposed [26]. 
Elsewhere we have set out some of the reasons why we 
believe a universal mechanism does not exist [9] and we 
will not address this issue directly here. However, it should 
be clear from our later discussion that the ferritins we have 
selected for detailed consideration do not follow the same 
mechanistic pathway and therefore a universal mechanism 
cannot exist. An additional important mechanistic issue 
that we have referred to above is that it is unclear whether 
the in vitro procedures used to study core formation in 
ferritins are always physiologically relevant. This is not 
least because most supply iron to the ferritin in the form 
of hydrated Fe2+ and it seems likely that within cells the 
available Fe2+ is bound to ligands, some of which may act 
as the iron donors to ferritins. As Philpott notes [29], “the 
iron chaperone field is in its infancy, with many more ques-
tions unanswered than resolved”, but iron donors for fer-
ritins have been identified [29, 30]. Leaving aside the issue 
of the supply of Fe2+ to ferritin for now, we believe the 
mechanistic studies of the aerobic uptake and oxidation of 
Fig. 2  Comparison of 
B-channels in wild-type E. coli 
BFR and its D132F variant. 
One of the B-type channels 
formed at the interface between 
three subunits is displayed with 
the separate subunits coloured 
magenta, cyan and green. 
The amino acids forming the 
B-channels and the molecular 
surfaces generated with a 0.8 Å 
solvent probe radius (to mimic 
the hydrated Fe2+ substrate) are 
displayed for wild-type BFR 
(a, c) and its D132F variant 
(b, d). The D132F variant was 
constructed along with other 
variants involving residues lin-
ing the B channels to investigate 
whether the B channels are 
important for iron core forma-
tion [16] Constructed from PDB 
1D3E1L. Reproduced with per-
mission from Wong et al. [16]
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Fe2+ by ferritins is physiologically relevant where O2 is the 
natural oxidant.
In the 79 years since Laufberger first described ferritin 
[1] what must have struck most chemists encountering it 
for the first time is the fact that as much as 24 % of the 
protein by weight may be Fe3+ and yet it is highly solu-
ble in water at pH 7. For many of us this is the central 
feature of ferritins, and is an observation that probably 
accounts for the description of ferritin as an iron-storage 
protein. However, iron-storage is a functional term. Is 
the primary function of all ferritins iron storage? Prob-
ably not! Andrews [7], Theil [8] and Arosio et al. [10] 
have considered the functional aspects of ferritins in 
recent reviews and they provide impressively long lists of 
physiological functions in addition to iron trafficking and 
storage. Most of the additional functions they list though 
can be reduced to the chemical property of being an anti-
oxidant. Indeed, it is clear that the genes encoding some 
prokaryotic ferritins are only induced under conditions of 
oxidative stress (see, for example, [31, 32]). Whether this 
is because the ferritin that is upregulated reduces oxida-
tive stress by catalyzing the removal of O2 or reactive 
oxygen species as Fe3+ is produced from an Fe2+ sub-
strate, removing excess Fe2+ ions, or providing a source 
of iron for the production of enzymes such as catalase, 
which directly reduces oxidative stress by disproportion-
ating H2O2, has not always been demonstrated but the 
role in reducing oxidative stress is clear. Steifel and Watt 
[13], noting the redox activity of Fe3+ core formation 
from Fe2+, suggested that one of the roles of BFR was 
as an electron source, something that might fit in with the 
earlier description of BFR as a cytochrome [13, 33]. The 
precise physiological functions of ferritins is an impor-
tant topic in its own right, but it is also important in terms 
of considering mechanisms of iron core formation in 
ferritins in vitro. The evolutionary pressures on proteins 
are such that provided the protein can perform its func-
tion satisfactorily mutations can be accepted [34]. This 
means, for example, that if the main function of a ferritin 
is relief of oxidative stress by the rapid removal of O2, 
the key residues involved in this might be more resistant 
to mutation than the corresponding residues of a ferritin 
whose main role is to sequester excess iron in a form that 
can be rapidly mobilised when the cell requires it, assum-
ing, of course, that the key residues for these two activi-
ties are not the same. As we consider individual ferritins 
below, the issue of the physiological relevance should be 
borne in mind.
In addition to considering how ferritins build up a core 
in vitro we briefly describe recent advances in determining 
how ferritins release iron. The release of iron by ferritins 
is not as well understood as their uptake of iron but it is an 
important subject for those ferritins that are not dead-end 
iron stores. Though iron release is not well described yet, 
as we shall see it is already apparent that there is great 
diversity in physiological iron release processes. Thus, just 
as a universal mechanism does not exist for iron uptake nor 
is there a universdal mechanism of iron release.
The iron cores of ferritins
If ferritins are primarily iron-storage proteins then what form 
they store the iron in becomes an important subject, as this 
will be the end product of storage and, perhaps, the starting 
point for iron release. However, if the primary function of a 
ferritin is something other than iron storage then the nature 
of the iron core may not be so important. Unfortunately, we 
usually don’t know what the primary function of a ferritin is, 
so are not sure how important knowledge of its native iron 
core is. This uncertainty, coupled with the current preva-
lence of studying recombinant proteins, means that the form 
of the stored iron in most native ferritins has not received 
much attention in the past 30 years. Because of this we shall 
briefly review the earlier literature on the cores of native fer-
ritins as well as consider more recent studies on human fer-
ritin. Before doing so we should note that for all ferritins, the 
nature of the core appears to be influenced more by the envi-
ronment the ferritin is in than the protein coat itself. This is 
evident from the studies of ferritin cores reconstituted in vitro 
compared to the native cores they had on isolation that are 
described below. In this context, an important point to note is 
that some of the studies of native human ferritins have been 
with samples from patients suffering with a variety of dis-
eases that affect iron metabolism, such as beta-thalassemia 
[35] or haemochromatosis [36], and whether the molecular 
details of the native ferritin cores found in these studies can 
be extrapolated to the ferritins from humans not suffering 
from such a disease is not clear, particularly since the flow 
of iron into the ferritins is likely to be different under normal 
and iron overload conditions. Nevertheless, such studies are 
revealing and we have referred to some below.
Heterogeneity and maximum iron content of core
Native ferritins are heterogeneous because though the protein 
shells of a pure ferritin may be homogeneous the iron cores 
are not [3, 37]. This is a major complication for many physi-
cal techniques. For example, it is largely because of this that 
X-ray structures of ferritins containing a core have not revealed 
what the core looks like at atomic resolution: the crystals have 
regularly packed protein shells whose diffraction patterns yield 
their structure, while the irregularly packed cores do not. Fisch-
bach and Anderegg [11] used isopycnic centrifugation to sepa-
rate horse spleen ferritin into relatively homogeneous fractions 
as determined by size, thus partially overcoming the problem 
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of heterogeneity, and found that what they called “full” ferritin 
had a molecular mass of ~900 kDa and contained ~4300 Fe3+ 
ions per molecule. However, even though the cores of ‘full” 
ferritin were about the same size they were irregularly packed 
in crystals, which still prevented their structures from being 
determined by X-ray diffraction [38].
Composition
The composition of native cores varies considerably 
(Table 1), with some being phosphate-rich. We have not 
been selective in our tabulation of data for the cores of BFR 
and FTN as, apart from those listed in Table 1, we are not 
aware of additional relevant studies of these. Therefore, 
although the literature on in vitro mechanistic studies of 
E. coli FTN and BFR is extensive, there are no reports of 
the characteristics of their native cores beyond the early 
description [55] of the 57Fe Mössbauer spectrum of E. coli 
cells loaded with 57Fe which identified the spectroscopic 
signature of a polynuclear iron species that had the char-
acteristics of an amorphous material, assumed to be the 
BFR subsequently isolated from such cells, and a later 
57Fe Mössbauer study [56] of wild-type, bfr− and ftn− cells 
which showed the FTN to have a magnetically ordered 
core, and thus must at least have had limited crystallinity.
There is a significant difference between some ferritins 
in their phosphate contents beyond the relative amounts. 
The phosphate of ferritins with a low Fe:P ratio is incor-
porated into the core in a way that means it is not removed 
without loss of iron, whilst the phosphate of the ferritins 
with high Fe:P ratio is relatively easy to remove and does 
not affect the structure of the core iron. This is consistent 
with a model of the core for the low phosphate containing 
ferritins being an Fe3+ poly-oxo-hydroxide polymer with 
phosphate associated with its surface, and thus close to the 
inner surface of the ferritin protein shell, rather than inte-
grated into the mineralized iron core as is the case with the 
phosphate-rich cores [3, 57, 58].
Morphology
The morphology of native cores varies considerably, 
with some being highly crystalline, others being highly 
amorphous and others being somewhere between the two 
Table 1  Characteristics of iron cores of native ferritins
a The entries in this table are for the ‘as-prepared’ heterogeneous ferritins and thus the iron and phosphate contents represent an average
b C crystalline, L limited crystallinity, A amorphous, n.d. not determined
c Native animal ferritins have been isolated from a wide variety of sources with iron contents from negligible to full loading but often the core 
morphologies of the samples were not reported, probably because EM facilities were not as available as now. Typical early examples are: horse 
spleen ferritin with an average iron content of 20–23 % and phosphate content of 1.5–2.0 % which was homogeneous by electrophoresis (i.e. 
had a uniform protein shell) but inhomogeneous in the ultracentrifuge (i.e. had a variable core size) [37], and ferritin from tadpole red blood 
cells with an average iron content of 12 % and a range of 8–24 % [49]. We have only cited a selection of studies in the table where a full analysis 
of core composition, size and morphology was reported. Chasteen and Harrison [50] provide further examples
d mid = cells harvested in mid-exponential phase; stat = cells harvested in stationary phase
e The P. aeruginosa samples used in these studies were mixtures of BFR and FTN (see text) although this was not known at the time and it was 
thought [51] the two types of subunit detected formed a BFR heteropolymer similar to the H/L heteropolymers of animal ferritins [3, 8] (see 
text). An example of the SDS-PAGE gels for a typical preparation of the P. aeruginosa samples is Fig. 4 of al-Massed et al. [52]. Importantly, 
however, the 57Fe Mössbauer spectra for samples of purified P. aeruginosa ferritins and intact cells [53] over a wide temperature range revealed 
only one type of core suggesting that both its BFR and FTN have similar amorphous phosphate-rich cores. All these studies were carried out 
with cells grown on a high nitrate medium. On a low nitrate medium 57Fe Mössbauer spectra of P. aeruginosa cells contained two signals, one 
likely from the kind of amorphous core observed in the studies described above and a signal from a more ordered core which likely contained 
regions of limited crystallinity [54]. As far as we aware isolation of ferritins from such cells has not been reported so it is not known whether the 
more ordered core comes from BFR or FTN
Ferritina Number of iron ions Number of phosphates Fe:P ratio Core morphologyb Refs.
Animal ferritins See footnote c
Human spleen ferritin 2200 105 21:1 C [39]
Chiton (Acanthopfeura hirtosa) 1500–2500 40–70 36:1 L [40]
Limpet (Patella laticostata) 2000 45 44:1 L [40]
Pea phytoferritin 1800 640 2.8:1 A [41]
Clover phytoferritin 1300 325 4:1 n.d. [42]
Helicobacter pylori FTN 900 640 1.4:1 n.d [43]




1.4:1 A [13, 44]
Rhodobacter capsulatus BFR 900-1000 600 ~1.6:1 A [45]
Pseudomonas aeruginosa BFR/FTNe 700 410 1.7:1 A [46–48]
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extremes (Table 1). EM [39, 57, 59] and 57Fe Mössbauer 
spectroscopy [40, 47, 60] have been the main methods for 
determining core morphologies, with both being applica-
ble to ferritins in situ in biological samples as well as when 
purified. EM allows the crystallinity of cores to be charac-
terized directly while 57Fe Mössbauer spectroscopy over 
the temperature range 200–1.3 K allows the intrinsic mag-
netic properties of the core to be studied, which report on 
the long-range order within the core.
The size distributions of cores determined by EM have 
been widely reported. For as-prepared samples that have 
not undergone fractionation there is usually a large range 
of sizes. Examples are: horse spleen ferritin with a core 
size distribution having diameters from 24 to 78 Å and a 
median value of 50–60 Å [57] and P. aeruginosa BFR/FTN 
(see note 5 to Table 1) from 40 to 80 Å and with a median 
value of 60–65 Å [46]. A fraction of the horse spleen fer-
ritin studied by Mann et al. [57] containing ~3000 iron 
ions per molecule had a more homogeneous distribution 
but its core diameter still varied over the range 30–70 Å. 
Clearly, with the considerably different amounts of iron 
in the cores of horse spleen ferritin and the P. aeruginosa 
samples, the similarity in their core sizes means the cores 
of the P. aeruginosa ferritin samples were much less dense 
than the cores of horse spleen ferritin. This is consistent 
with the phosphate being an integral part of the core, some-
thing confirmed by EXAFS studies of A. vinelandii BFR 
[58]. Electron diffraction patterns for horse spleen ferritin 
and human ferritins measured by EM are indicative of the 
core having a structure resembling that of ferrihydrite (see 
below). Electron diffraction for A. vinelandii BFR and P. 
aeruginosa ferritin samples showed no evidence of crystal-
linity [57] although some preparations of native A. vine-
landii BFR have been reported to contain small regions of 
crystalline ferrihydrite within their otherwise amorphous 
phosphate-rich cores [44].
Since polynuclear clusters of Fe3+ contain antiferro-
magnetically coupled high-spin Fe3+ ions, their 57Fe Möss-
bauer spectra can be temperature dependent because their 
magnetic properties are affected by the variation in thermal 
energy [47, 60]. An important phenomenon for interpret-
ing ferritin 57Fe Mössbauer spectra is superparamagnetism. 
This occurs in magnetically ordered materials where tran-
sitions of the sublattice magnetizations between energeti-
cally equivalent crystallographic directions are thermally 
activated. The total electron spin associated with the net 
magnetic moment of a ferritin core is confined to certain 
energy levels corresponding to allowed orientations of the 
spin with respect to the axis of quantization. The ground 
state can adopt one of two orientations, the so-called ‘easy’ 
directions, which are equal in energy and correspond to 
spin up and spin down. These two ‘easy’ directions are 
separated by an energetic barrier, or ‘hard’ direction. At 
temperatures where there is sufficient thermal energy to 
allow the spins to surmount the hard barrier the spins can 
flip orientation and the 57Fe Mössbauer spectrum is a quad-
rupole-split doublet. At lower temperatures where there is 
insufficient thermal energy to allow the spins to overcome 
the barrier the 57Fe Mössbauer spectrum is magnetically 
split and becomes a sextet. As samples are usually hetero-
geneous there is a range of core sizes with differing mag-
netic properties so that the doublet and sextet components 
co-exist in the spectrum. The average blocking temperature 
of a sample is usually considered to be the temperature at 
which 50 % of the 57Fe Mössbauer spectrum is the mag-
netically split sextuplet signal and 50 % the quadrupolar 
split doublet. Increasing crystallinity of the core is asso-
ciated with higher blocking temperatures. On this meas-
ure, horse spleen ferritin and human ferritin having much 
higher blocking temperatures than A. vinelandii BFR and P. 
aeruginosa BFR/FTN (see note 5 to Table 1) and are con-
sidered [44, 47] to be more ordered than the bacterial ferri-
tins, in keeping with the EM studies referred to above.
EPR [61] and magnetic circular dichroism [62] spec-
troscopies also reveal differences between crystalline and 
amorphous cores of ferritins, with the theoretical under-
standing of the EPR spectrum of crystalline cores suffi-
ciently developed to allow the blocking temperature to be 
determined. As Wajnberg et al. [61] note, the blocking tem-
perature determined by EPR spectroscopy is different from 
that measured by 57Fe Mössbauer spectroscopy because the 
two methods have different measurement times and they 
describe a procedure that allows the two values to be com-
pared taking into account this variable.
Structures of crystalline cores
Harrison and her co-workers noted that the X-ray diffrac-
tion pattern of the crystalline cores of human and horse 
spleen ferritins resembled those for the mineral ferrihydrite 
[63], and ever since then successive studies with a variety 
of techniques have reaffirmed the view that ferrihydrite is 
the dominant component of crystalline cores [3, 8]. Fer-
rihydrite has the chemical composition 5Fe2O3.9H2O, and 
recently Sadeghi et al. [64] have demonstrated that the 
aqueous chemistry of Fe3+ ions in the absence of ferritins 
generates an Fe13 polymer that resembles ferrihydrite. This 
observation is consistent with the view that ferritins pro-
vide an enclosed reaction vessel in which an iron-rich core 
can be laid down rather than a surface that catalyzes forma-
tion of a particular kind of iron-containing polymer.
Pan et al. [36] reported that scanning transmission elec-
tron microscopy of ferritin in liver biopsy samples from a 
patient suffering with type 2 hereditary haemochromatosis, 
which contained 200–4000 iron ions per ferritin molecule, 
suggested that their cores were composed of ferrihydrite 
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contained in eight core particles with an arrangement reflect-
ing the cubic symmetry of the protein shell so that the core 
particles were associated with the eight threefold symmetry 
channels. This extends considerably the description of the 
particle structure of the core first discussed in earlier pub-
lications using EM, which were based on four or six com-
ponents. The association of the core particles with the three-
fold symmetry channels allowed Pan et al. [36] to propose a 
scheme for core formation in human ferritin based on Fe2+ 
entering the central cavity via the threefold channels. Their 
model is consistent with other data that shows Fe2+ ions 
enters the central cavity via the threefold channels [4, 8]. 
Theil and her colleagues provide compelling evidence [20, 
65] on this point by observing metal ions in transit through 
the protein coat with X-ray crystallography. They show 
a line of metal ions, 15 Å long, that spans the protein coat 
through the through-fold channels, and note that each Fe2+ 
ion travels a distance of 28 Å through the protein to reach the 
ferroxidase centers. However, Pan et al. [36] suggest the bulk 
of the Fe2+ ions gets oxidized in the cavity whilst the scheme 
that Theil and her colleagues have developed has it being 
oxidized at the ferroxidase centers. It remains to be seen 
whether this is a consequence of Pan et al. [36] studying fer-
ritin formed under high iron conditions that overwhelm the 
relatively few ferroxidase centers in the molecule, or whether 
the core structure Pan et al. [36] observe can be formed by 
the oxidation and transit pathway in the Theil model [20, 
65]. What is clear is that the experimental data used to iden-
tify the site of oxidation in the Theil model is extensive and 
convincing while Pan et al. [36] did not provide independ-
ent experimental data to identify the site of oxidation in their 
model.
Influence of the protein shell on characteristics of the 
core
An interesting question arising from these observations that 
has occupied many researchers in the field, is why are some 
cores highly crystalline and others amorphous? It is well 
established that it is not the protein shell that is responsible 
since reconstituted cores of bacterioferritins in vitro can be 
well-ordered (for example, [56, 57]). Nor is the presence of 
large amounts of phosphate in the core a necessary require-
ment since the low-phosphate cores of molluscan ferritins 
have limited crystallinity (Table 1), and the phosphate-rich 
core of A. vinelandii BFR, though described as amorphous 
in most reports [57], has regions of limited crystallinity 
[44]. Generally, authors of studies addressing this issue 
suggest it is the rate at which cores are formed that deter-
mines their degree of ordering, or a combination of the 
rate and the amount of ligands other than hydroxide and 
oxide that is available to the newly formed Fe3+ ions that 
is important. A faster rate is taken to lead to a less ordered 
core. Thus the protein shell does not influence directly core 
morphology, and nor does it influence the size of the core. 
As Theil [66] notes, mineral sizes are relatively independ-
ent of constraints imposed by the protein shell and reflect 
iron bioavailablity for mineralization that is normally far 
below the maximum capacity.
However, an important feature of animal ferritins illus-
trates that the protein shell can influence the characteristics 
of the core. Animal ferritins are generally composed of two 
type of subunit, H for Heavy and L for Light, that coas-
semble to form heteropolymers with the relative numbers 
of H and L chains in a 24mer heteropolymer being tissue-
specific [3, 8]. The properties of the H and L subunits are 
different, with only the H chain containing a ferroxidase 
center, and this means that the rate at which heteroploymers 
can accumulate iron varies [67, 68]. This, in turn, seems to 
correlate with characteristics of the core since different het-
eropolymers isolated from different tissues have different 
crystallinities and shapes [35, 69].
Studies of native bacterioferritins
Bacterioferritins have been identified in numerous species, 
but studies of the native iron-loaded forms are not that 
extensive. Steifel and Watt [13] were the first to show that 
native BFR had a different mineral core to mammalian fer-
ritins by reporting that Azotobacter vinelandii BFR con-
tained a phosphate-rich core with an Fe:P ratio of 1.4:1. 
Subsequently it was reported that the native BFRs of Pseu-
domonas aeruginosa and Rhodobacter capsulatus also had 
phosphate-rich cores. The use of 57Fe Mössbauer spec-
troscopy to study BFRs has been particularly revealing 
since it is a method that can be applied to intact cells. In 
the case of P. aeruginosa, 57Fe Mössbauer spectra of intact 
cells grown to stationary phase on media enriched with 
57Fe were similar to those of purified native BFR [53]. 
Though it was known at the time of the 57Fe Mössbauer 
study that P. aeruginosa had at least two ferritin genes and 
the polypeptides from both were present in the cells, it 
was not known whether they formed homopolymers or a 
heteropolymer. Since then it has been established that the 
bfrA gene actually codes for a FTN [70], and thus might 
more properly be called ftnA. The two genes are regulated 
by iron differently, with ftnA (previously bfrA) constitu-
tively expressed during the exponential growth phase and 
iron regulated on transition into the stationary phase, while 
bfrB is strongly upregulated under high-iron conditions 
[32, 71]. This has led on to detailed studies in vitro of the 
BFR B homopolymer (see below). What it means for the 
57Fe Mössbauer spectra of intact cells [53] from which the 
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ferritin studied by Moore and his colleagues was isolated 
[46, 51] is that the spectra reported are likely to be from 
a mixture of BFR B and FTN A (see note 5 to Table 1), 
with both having similar amorphous cores, or the FTN not 
having a sufficiently large core to give a detectable mag-
netically ordered spectrum indicative of at least limited 
crystallinity, as observed for other FTNs [43, 56]. The 
difference in genetic regulation of the two P. aeruginosa 
ferritin genes is consistent with FTN A being the general 
housekeeping ferritin for iron storage and BFR B being 
involved in relief of oxidative stress [32, 71].
57Fe Mössbauer spectra of intact Rhodobacter capsula-
tus cells have also been reported [45]. R. capsulatus is a 
purple photosynthetic bacterium able to grow aerobically 
and anaerobically (photosynthetically). The native BFR 
isolated from aerobically grown cells contained an amor-
phous core of 900–1000 iron ions per 24mer with an Fe:P 
ratio of 1.5–1.7:1. The iron in the BFR cores in both aero-
bically and anaerobically grown intact cells was largely 
Fe3+ which raises the issue of what the oxidant for Fe2+ 
is in the anaerobically grown cells. The amount of BFR 
protein per cell was found to vary with iron content in the 
medium, being low when the medium was low in iron and 
high when the medium was enriched with iron, consistent 
with this BFR having a role in iron metabolism.
Ironically given that E. coli BFR is the best character-
ised BFR in vitro, its physiological role is not certain [56], 
though likely to be connected with control of oxidative 
stress as with other BFRs. From growth and 57Fe Möss-
bauer studies [56] of wild-type, ftn− and bfr− E. coli strains 
FTN appears to fulfill the general iron housekeeping role, 
since the 57Fe Mössbauer spectra of wild-type cells grown 
to stationary phase reveal that the majority of the iron pre-
sent is in FTN.
Mechanistic studies of Escherichia coli 
bacterioferritin (EcBFR)
The intra-subunit ferroxidase center of E. coli BFR in an 
Fe3+-bound form has Fe1 and Fe2 both ligated by terminal 
glutamate and histidine residues, and by two bridging glu-
tamate residues (Fig. 3). The inter-iron distance is 3.6 Å in 
the E. coli BFR structure [23], similar to that reported for 
the di-Fe3+ forms of the center in D. desulfuricans (3.7 Å) 
and A. vinelandii (3.5 Å) BFRs [15, 72]. In each case, there 
is additional bridging electron density that is consistent 
with an oxygen-containing bridging species. In the Fe2+-
bound state there is an increase in the Fe1 to Fe2 distance 
towards ~4 Å with no additional bridging electron density 
between the irons [15, 23, 72]. In the absence of iron the 
ligands that form the ferroxidase center have the same con-
figuration as for the iron-containing center in most X-ray 
structures. However, in two structures, those for apo-BFR 
in the presence of phosphate and the D132F variant, the 
side chain of His130 is oriented away from the empty iron-
binding site similarly to the equivalent residue of P. aer-
uginosa BFR B (see below). Thus, as with P. aeruginosa 
BFR B, His130 appears to be conformationally flexible. An 
additional Fe2+-binding site has been observed in EcBFR 
with the Fe2+ ion coordinated by Asp50, His46 and three 
water molecules [23]. This site is located on the inner 
surface of each subunit, facing the cavity. The distance 
between this inner surface site and the nearest ferroxidase 
center iron is 9.2 Å (Fig. 3). Fe3+ has not been detected in 
X-ray structures at this additional site, here called the IS 
site (after inner surface). As described below, the IS site is 
important for transmitting electrons from Fe2+ ions in the 
cavity to the ferroxidase center, and perhaps also iron to the 
growing mineral.
Fig. 3  The ferroxidase center of EcBFR. a The diiron ferroxidase 
center of BFR is shown with coordinating residues (Glu18 and His54 
are terminal ligands to Fe1; Glu94 and His130 are terminal ligands 
to Fe2; Glu51 and Glu127 bridge Fe1 and Fe2), along with the inner 
surface iron site (FeIS) with coordinating residues (His46 and Asp50), 
and closely lying aromatic residues (Tyr25, Tyr58 and Trp133). b The 
apo-form of the ferroxidase center of BFR showing that residues that 
act as ligands to the irons are located in similar positions, with the 
exception of His130, which, in this apo-structure, has swung away 
from the iron binding sites such that the center adopts an open con-
formation. a and b generated using PyMol with PDB files 3E1M and 
3E1L, respectively
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Early studies of the aerobic addition of Fe2+ to E. coli 
apo-BFR identified three kinetic phases [73], the first of 
which, phase 1, is the binding of Fe2+ ions to BFR and the 
other two oxidation of Fe2+ ions catalyzed by BFR. The 
fast oxidation step, phase 2, saturates at two Fe2+ ions per 
subunit, and was later shown through mutagenesis stud-
ies to be oxidation of Fe2+ ions at the ferroxidase centers 
[22], which occurs before any iron is deposited in the cen-
tral cavity. The slower oxidation step, phase 3, is associ-
ated with deposition of Fe3+ ions in the central cavity. 
Examples of the kinetic traces observed are given in Fig. 4. 
These show the time dependence of the increase in absorb-
ance at 340 nm associated with oxidation of Fe2+ to Fe3+ 
for wild-type BFR and three ferroxidase center variants. 
The lower traces show the rapid phase 2 reaction of wild-
type BFR, which is absent from the ferroxidase center vari-
ants, and the upper trace the slower phase 3 reactions. Two 
points are notable from these data. First, for rapid oxidation 
of Fe2+ ions intact ferroxidase centers are essential, and 
second, that intact ferroxidase centers are not essential for 
complete oxidation of the added Fe2+ to Fe3+. This latter 
point is shown by the similar overall absorbance changes 
for wild-type BFR and the three variants. This is one of the 
earliest indications that while rapid oxidation of Fe2+ ions 
by BFR requires functioning ferroxidase centers, at least 
one other Fe2+ ion oxidation pathway exists in BFR that 
does not need the ferroxidase center. This may well involve 
the surface of a growing Fe3+ core in the cavity acting to 
catalyze Fe2+ oxidation, a mechanism widely discussed 
in the ferritin literature and relevant to the mechanism of 
core formation in human ferritin put forward by Pan et al. 
[36] and discussed above, but not one considered further 
here (for example, [50]). An important observation in these 
early kinetic studies was that the phase 2 reaction was 
only observed once per apo-BFR sample, suggesting that 
some or all of the Fe3+ product remained in the ferroxidase 
center preventing further Fe2+ ions from binding and being 
oxidized there [22]. EPR studies supported this by show-
ing that a significant fraction of the added Fe2+ ions was 
not visible as mononuclear Fe3+ following oxidation. Sev-
eral models were put forward to explain these data with the 
simplest being that the Fe2+ dimers occupied the ferroxi-
dase centers and became oxidized with some of the product 
Fe3+ dimers breaking up. Later EPR studies [74] quantified 
the amount of monomeric Fe3+ ions following the oxida-
tion of the first 48 Fe2+ ions per apoBFR and found that 
only 3 % of the iron in BFR was monomeric, leading to 
the conclusion that the monomeric Fe3+ complex is not a 
major product of the ferroxidase reaction. Structural stud-
ies were entirely in agreement with this in that iron-soak 
experiments with EcBFR crystals revealed full occupancy 
of the ferroxidase sites in both Fe2+ and Fe3+ states [23]. 
Furthermore, recent circular dichroism (CD) and mag-
netic CD data confirmed that upon O2 redox cycling the 
diiron ferroxidase center remains intact while the IS site is 
vacated [31].
Though the majority of mechanistic studies of EcBFR, 
indeed, all ferritins, have concentrated on the Fe2+ substrate the 
nature of the oxidant is also important. Despite our comments 
above about the laying down of Fe3+ cores in some bacterial 
cells grown anaerobically, in vitro studies have largely concen-
trated on the use of O2 as an oxidant, and occasionally H2O2 
[75]. Oximetry measurements [74] with EcBFR have shown 
that the ratio of Fe2+ oxidised to O2 reduced is 4, indicating 
that all the electrons for the reduction of the O2 come from 
Fe2+ oxidation. H2O2 is a more efficient oxidant of the EcBFR 
Fig. 4  Kinetic traces for Fe oxidation in EcBFR. a Absorption 
change at 340 nm measured as a function of time after the addition 
of 400 Fe2+ ions per apo-protein molecule to samples of wild-type, 
E18A, E51A and E94A BFR, as indicated. For the wild-type protein 
this profile yields the phase 3 rate. b Absorption change at 340 nm 
followed by spectrophotometry over the first 20 s following the addi-
tion of 400 Fe2+ ions per apo-protein molecule. For the wild-type 
protein this profile yields the phase 2 rate. Proteins were in 100 mM 
MES buffer, pH 6.5 at a final concentration of 0.5 µM. Temperature 
was 30 °C, pathlength 1 cm. Reproduced with permission from Le 
Brun et al. [22]
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di-Fe2+ ferroxidase center but this does not affect the Fe2+:O2 
stoichiometry in competition experiments with O2 [75].
As noted above, ferroxidase activity in EcBFR is essential 
throughout rapid core formation and this, together with the 
failure to detect a second round of phase 2 activity after the 
addition of 48 Fe2+ ions to apo-BFR, and the stability of the 
oxidized form of the dinuclear center evident from kinetic, 
crystallographic and EPR studies [22, 23, 74], and now CD 
and MCD data [31], led to a proposed mechanistic model 
(Fig. 5) for mineralization in which the ferroxidase site func-
tions as a true catalytic center, continually cycling between 
its oxidized (bridged di-Fe3+) and reduced (di-Fe2+) forms. 
In this model [76], the catalytic cycling of the ferroxidase 
center is driven by the oxidation of Fe2+ ions in the central 
cavity, with the electrons resulting from this passing to the 
oxidized ferroxidase center to effect its reduction back to the 
di-Fe2+ form, which is then primed to react again with O2 
(or H2O2). This model requires the existence of an electron 
transfer route from the cavity to the ferroxidase center, and 
at least some elements of this have now been established 
(Fig. 5). Disruption of the IS site described above by singly 
replacing His46 and Asp50 with alanines did not affect the 
rapid oxidation of Fe2+ ions at the ferroxidase site, phase 2, 
but did severely inhibit subsequent mineralization, phase 3, 
suggesting that the IS site forms part of an electron transfer 
pathway between Fe2+ ions in the cavity and the ferroxi-
dase center, with FeIS becoming incorporated in the growing 
core. More recently, we found that mineralization in EcBFR 
depends on three aromatic residues near to the ferroxi-
dase center, Tyr25, Tyr58 and Trp133, and that a transient 
Fig. 5  Summary of the proposed BFR mineralization mechanism. 
Two Fe2+ ions access the ferroxidase site via B-type channels [16] 
and undergo oxidation to the bridged di-ferric form (with either O2 
or H2O2 as oxidant [75]. The oxidized di-Fe
3+ form of the site is 
stable [23]. Additional Fe2+ ions binds at the inner surface site (IS 
site) and undergoes oxidation to Fe3+. A second electron is derived 
from the oxidation of the nearby Tyr25 side chain, generating a radi-
cal and regenerating the di-Fe2+ form of the ferroxidase site. The 
radical decays indirectly through the oxidation of a second Fe2+ ion 
(at an unknown location), and the oxidized iron at the inner surface 
site nucleates or is incorporated into the growing mineral core. The 
di-Fe2+ ferroxidase site undergoes oxidation again via reaction with 
O2 or H2O2. At this point, the catalytic site has returned to its rest-
ing state, ready to react again when Fe2+ ions are present. Hydrolysis 
of the accumulating hydrated Fe3+ ions in the cavity leads to mineral 
formation. Adapted from Bradley et al. [76]
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radical detectable by EPR is formed on Tyr25. The key 
kinetic observations were that the single site-directed vari-
ants, in which each residue was substituted with phenylala-
nine, had phase 2 activities similar to that of wild-type BFR 
but considerably impaired phase 3 activities upon the addi-
tion of 400 Fe2+ ions per 24mer, with mineralization rates 
of 15 % (Y25F), 30 % (Y58F), and 25 % (W133F) relative 
to wild type BFR [76]. The observations of the importance 
of the IS site and the detection of a transient radical species 
associated with Tyr25 provide important evidence about the 
origin of the two electrons required to reduce the oxidized 
ferroxidase site. We proposed [76] that one electron comes 
from the oxidation of the inner surface site Fe2+, while the 
other is from Tyr25, generating the radical, which is then 
quenched by an electron from a second Fe2+ ion that is 
probably located in the cavity. The net effect of this is that 
two Fe2+ ions in the cavity are oxidized with the delivery of 
two electrons to the di-Fe3+ ferroxidase center (Fig. 5). This 
mechanism enables the near simultaneous arrival of the two 
electrons at the oxidized ferroxidase site, which minimises 
the possibility of single electron reduction of O2 or H2O2, 
and the accidental release of toxic reactive oxygen species, 
in keeping with a role for EcBFR in controlling oxidative 
stress.
The issue of how Fe2+ ions access the empty BFR protein 
shell has been addressed with site-directed mutagenesis [16]. 
Blocking the B-channels by mutating Asp132 to Phe (Fig. 2) 
has been most revealing. While the structure of the D132F 
variant was unaffected beyond the substituted side chain, the 
rates of both the phase 2 and phase 3 reactions were signifi-
cantly reduced compared to the wild-type rates, indicating 
that the B-channels are a major route for the entry of iron to 
the ferroxidase center and the central cavity of EcBFR.
The assay conditions used to explore the aerobic core for-
mation in the previous paragraphs generate a more crystalline, 
and relatively phosphate-free core, than is observed for native 
EcBFR. Aitken-Rogers et al. [77] explored this by adding 
phosphate to the solutions for in vitro core formation under 
similar conditions to those employed for the mechanistic stud-
ies leading to the proposed mechanism set out in Fig. 5. The 
key findings from this [77] study were: (i) The iron core had a 
composition and EPR properties characteristic of native cores, 
unlike the core generated under solution conditions without 
added phosphate; (ii) Phase 2 Fe2+ oxidation—i.e. occupation 
of the ferroxidase center by two Fe3+ ions—occurred similarly 
in the presence or absence of added phosphate; (iii) Phase 3 
oxidation rates were significantly enhanced in the presence of 
phosphate. In terms of the mechanism set out in Fig. 5, this 
suggest that the rate–limiting steps of the core formation reac-
tion lies with events at the core rather than with reduction of 
O2 at the ferroxidase center. EPR studies [78] suggested that 
phosphate plays a role in shepherding iron into the central cav-
ity. Therefore, in terms of the key mechanistic steps involved 
in Fe2+ oxidation and O2 reduction, the low-phosphate in vitro 
conditions employed by Bradley et al. [76] probably mimic 
the key stages in the physiological build-up of an iron core in 
terms of the intermediates involved.
Mechanistic studies of Pseudomonas aeruginosa 
Bacterioferritin B (PaBFR)
Rivera and his colleagues have shown that P. aeruginosa 
BFR B lays down an iron core differently to EcBFR despite 
the marked structural similarity between the two (70 % 
identity), which extends to the same residues forming 
the ferroxidase center in both [27]. However, unlike with 
EcBFR, the ferroxidase center of PaBFR is unstable and 
its occupation by iron has only been detected in the X-ray 
structure of crystals soaked in a solution containing Fe2+. 
In this di- Fe2+ structure, the Fe–Fe distance is ~4 Å with 
no bridging electron density between the irons, as seen for 
EcBFR (Fig. 3). A striking finding from the X-ray struc-
tures is that the orientation of His130 relative to the other 
ferroxidase center ligands is variable. In the iron loaded 
center the His130 side chain is bound to an iron ion but in 
the metal-free site it is rotated away from the ferroxidase 
center, similarly to His130 of D132F EcBFR [16]. Rivera 
and his colleagues [27] call the two conformations of 
His130 in PaBFR the “gate open” and “gate closed” con-
formations, with the latter being the conformation bound 
to an iron ion in the filled ferroxidase center. The switch 
between the two conformations is an important step in their 
mechanism of core formation in this ferritin.
There are substantial difference between E. coli and P. 
aeruginosa BFRs in the kinetics of their aerobic oxidative 
accumulation of Fe2+ ions. Though PaBFR, like EcBFR, 
has two phases at low ratios of Fe2+:BFR (≤100) the 
slower phase, which is due to mineralization in the central 
cavity, becomes progressively faster as the ratio is increased 
and eventually obscures the initial fast phase [27]. How-
ever, at low ratios the fast phase does not saturate and the 
transition between the fast and slow phases is accompa-
nied by a small decrease in the absorbance change asso-
ciated with oxidation of Fe2+ ions. Weeratunga et al. [27] 
conclude from these observations that the fast phase cor-
responds to the oxidation of the di-Fe2+ ferroxidase center 
with the decrease in absorbance resulting from migration of 
the Fe3+ ions produced into the central cavity. The switch 
between the “gate open” and “gate closed” conformations 
of His130 is important for this migration because when the 
gate is open there is a direct path between the ferroxidase 
center and the internal cavity. We note that the same flex-
ibility of His130 in EcBFR is also considered functionally 
important but for entry of Fe2+ ions into the ferroxidase 
center rather than exit of Fe3+ ions [16].
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Mechanistic studies of Pseudo‑nitzschia multiseries 
ferritin (PmFTN)
Pseudo-nitzschia multiseries is a marine pennate diatom 
that plays a major role in global primary production and 
carbon sequestration in the deep ocean. Its ferritin is impor-
tant for sustaining its growth in iron-limited environments 
[79] and perhaps for this reason it appears that PmFTN 
is optimized for initial Fe2+ oxidation and not for miner-
alization of iron. Thus it may have a role in buffering iron 
availability and facilitating iron-sparing, the response of 
a cell to low levels of iron, rather than simply long-term 
iron storage. The X-ray structure of PmFTN shows it has a 
ferroxidase center and an additional iron-binding site, site 
C, nearby (Fig. 6). This arrangement is typical for bacte-
rial FTNs [9] and PmFTN is the first observation of it in 
a eukaryotic ferritin. The PmFTN site C is located closer 
to the ferroxidase center than is seen with the site C of 
prokaryotic FTNs but it shares two common ligands with 
them (Glu47 and Glu130). Glu130 of PmFTN connects a 
ferroxidase center iron at site B with C, and Glu44 is an 
iron ligand both at site C and on the inner surface of the 
protein shell.
X-ray studies of crystals soaked in iron-containing solu-
tions under varying conditions along with kinetic studies 
showed that Fe2+ ions bind stepwise in a dioxygen-depend-
ent manner, with the binding of the second iron ion the 
trigger for oxidation to occur. Glu130 and Glu44 were pro-
posed to shuttle metal ions between sites and this proposal 
led Pfaffen et al. [79] to carry out a mutagenesis study to 
investigate further the roles of these glutamates. As with the 
BFRs described above, the kinetics of the aerobic oxidation 
of Fe2+ ion catalyzed by PmFTN was central to the inves-
tigation. Like EcBFR, apo-PmFTN has a detectable phase 
2 reaction associated with the oxidation of Fe2+ to Fe3+ at 
the ferroxidase center and a slower phase 3 reaction, which 
is formation of the core mineral [79, 80]. The rate of the 
phase 2 reaction is amongst the highest reported for any 
ferritin. With the addition of two Fe2+ ions per subunit, the 
t½ for the phase 2 reaction was <50 ms, which is an order of 
magnitude faster than those measured for E. coli FtnA and 
human H ferritin under comparable conditions. The rate of 
the phase 2 reaction is so fast that Pfaffen et al. [79] sug-
gest that Fe2+ binding, rather than Fe2+ oxidation, is the 
rate-determining step of the reaction.
The ability of the variants to mineralize iron was inves-
tigated following addition of 400 Fe2+ ions per apo-protein 
(Fig. 7). The initial rates of the phase 3 reaction were simi-
lar for E44Q and wild-type PmFTN, whereas mineraliza-
tion in E44H PmFTN was significantly slower. The remark-
able finding, however, was that mineralization in the E130A 
variant occurred ~10-fold faster than in wild-type PmFTN. 
In all these variants the rate of the phase 2 reaction was not 
much changed from the wild-type protein. These data indi-
cate that PmFTN has evolved to oxidise Fe2+ ions at the 
ferroxidase center extremely rapidly, and to hold it there in 
a partially stable form, rather than rapidly transfer it to the 
central cavity for mineralization [80]. These observations 
provide clear experimental data in support of the proposal 
that the function of site C, at least in some ferritins, is to 
Fig. 6  The Ftn-type ferroxidase center and site C of P. multiseries 
Ftn. Structure of the eukaryotic Ftn-type ferroxidase center and site 
C of P. multiseries Ftn with Fe3+ ions bound generated using PyMol 
from PDB 4IWK [79]
Fig. 7  Stopped -flow spectroscopy of iron mineralization in wild 
type and variant PmFTN Absorbance changes at 340 nm showing 
Fe2+ oxidation following addition of 400 Fe2+/PmFTN to wild type 
and variant PmFTN (0.5 μM) in 0.1 MES pH 6.5 at 25 °C. The pro-
file of the plots from ~50 s onwards is determined by the rate of the 
phase 3 reactions. With the E130A variant this is complete in about 
300 s but with the wild-type protein it is only about 40 % done in 
1000 s. Note that in EcBFR under similar conditions the phase 3 
reaction with 400 Fe2+/EcBFR is complete in about 1000 s (Fig. 4a). 
Reproduced with permission from Pfaffen et al. [80]
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regulate the flux of Fe3+ ions through the ferroxidase site, 
as proposed by Treffry et al. [81]. The benefit of this in the 
case of the diatom ferritin may be to increase the availabil-
ity of iron taken up by ferritin for rapid redeployment of a 
scarce resource. In such an iron-buffering role, core forma-
tion in the internal cavity could be less important.
Furnishing other proteins with iron from ferritins
At various points in this article we have referred to ferritins 
as iron donors to other proteins and in this section we want 
to briefly consider this aspect. For ferritin to release iron 
without damaging itself, the core Fe3+ needs to be reduced. 
The product Fe2+ ions then have to traverse the protein 
coat and be released to acceptor molecules outside the fer-
ritin. Thus, as with the aerobic uptake of Fe2+ ions into 
ferritins, the release of Fe2+ ions from ferritins is linked to 
redox reactions. An important consideration in redox reac-
tions is the relative redox potentials of the electron donor 
and acceptor species. Watt and his colleagues have reported 
these for the cores of A. vinelandii BFR and horse spleen 
ferritin to be −420 ± 20 mV at pH 7–9 and ~−190 mV at 
pH 7, respectively [44, 82], suggesting that if we consider 
just the reduction of the core Fe3+ its physiological reduct-
ants would need to have low redox potentials. However, the 
reduction of the core Fe3+ and release of product Fe2+ ions 
to acceptor molecules are coupled events and the affinity 
of the Fe2+ ions for the acceptor molecules is important. 
This can be seen by considering the basic scheme of the 
commonly employed in vitro reductive iron release assays 
(Eqs. 1, 2) [83–85]:
The electron is usually provided by a small molecule 
reactant such as dithionite, flavin or a quinol, and the iron 
acceptor molecule (L) is generally ferrozine or bipyridyl, 
which yields a colored product whose formation can be 
monitored spectrophotometrically. Reaction (1) is normally 
slow and reaction (2) is much faster so that the overall rate 
of formation of Fe2+(L)x corresponds to the rate of reaction 
(1) with the equilibrium constant for the overall scheme 
dominated by the equilibrium constant for reaction (2). The 
significance of the iron acceptor molecule in this scheme 
is thus considerable which means that for physiologically 
relevant iron release studies, ideally the physiological 
acceptor molecules will be employed. This is in contrast 
to the aerobic iron uptake assays we have already consid-
ered, and is a consequence of the thermodynamic driving 
force for uptake generally being the downhill formation 
(1)Core − Fe3+n + e
−




(2)Fe2+ + xL→ Fe2+(L)
x
of Fe3+ species within ferritin whilst the driving force for 
iron release is the formation of the Fe2+ acceptor molecule 
complex. As with aerobic uptake of Fe2+ ions, in which 
long-range electron transfer through the protein is now rec-
ognized to be an important feature (e.g. Fig. 5), it appears 
that electron transfer through the ferritin protein is impor-
tant in reductive release of Fe2+ ions, at least in the small 
molecule studies using the assays of reactions (1) and (2). 
This is shown by the dependence of the overall rate of for-
mation of Fe2+(L)x on the redox potential of the electron 
donor [84, 85].
Iron donor molecules to ferritins and iron acceptor mol-
ecules from ferritins could be examples of metallochaper-
ones, iron binding proteins whose function is the intracel-
lular trafficking of iron between molecules. First identified 
for Cu2+ ions, metallochaperones are thought to be impor-
tant for other redox-active metal ions, including iron [29, 
86]. The clearest example of iron chaperones that work 
with animal ferritins has come from studies by Philpott and 
her colleagues with the Poly(rC)-binding proteins PCBP1 
and PCBP2 [29, 87]. PCBP1 was originally identified as an 
RNA binding protein but in 2008 Shi et al. [30] reported 
that it delivered iron to ferritin in human cells, and later 
studies [87] indicated that PCBP1 and PCBP2 delivered 
iron to many iron-requiring enzymes. Where PCBP1 and 
PCBP2 obtain the iron they pass on to ferritin and other 
enzymes has not been firmly established but at least some 
of it comes from a pool of labile iron present in the cell. 
Whether PCBP1 and PCBP2 are capable of acting as iron 
acceptors from ferritin has not been reported but if they are 
not the iron acceptor chaperones then presumably there are 
other iron chaperones waiting to be discovered!
BFR was the first ferritin for which a partner protein 
was identified, the so-called Bacterioferritin-associated 
ferredoxin, Bfd, which contains a single 2Fe/2S cluster 
[56, 88, 89]. A significant breakthrough in characterizing 
this came with the X-ray structure of P. aeruginosa Bfd 
bound to its BFR [90, 91]. The 24mer BFR bound 12 Bfd 
molecules at independent and identical binding sites that 
placed each 2Fe/2S cluster relatively close to one of the 12 
heme groups of the BFR. Parallel mechanistic studies [27, 
90, 91] showed that the presence of the bound Bfd helped 
mobilize iron from the core of BFR by feeding electrons 
to it via the heme groups. Since the gene for Bfd is wide-
spread in bacteria it is likely that reaction described by Yao 
et al. [90] is common. Above we have described the driv-
ing force for iron release to be the formation of the Fe2+ 
acceptor molecule complex, and with A. vinelandii BFR 
supporting evidence for this is that protein with a core of 
1000–2000 Fe2+ ions can be passed through gel filtration 
columns and studied spectroscopically without significant 
loss of iron provided a chelator is not present [82]. This 
leads on to the intriguing thought that if BFR also has an 
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iron acceptor protein within the cell, reductive iron release 
will involve not only Bfd but also another protein so a com-
plex of three kinds of protein may be involved. However, a 
prokaryotic iron chaperone has not been reported.
Up to now in this section we have described iron release 
from ferritins without damage to the protein coat but it has 
been known for many years that ferritin within animal cells 
can become damaged and get converted to an insoluble iron-
rich aggregate commonly called hemosiderin [92, 93]. How 
hemosiderin is formed is not understood but it is known 
it involves ferritin being transported to lysosomes and 
degraded. The recent striking discovery of ferritinophagy 
[94–96], an intracellular degradative process whereby iron 
is released from ferritin in mammalian cells, may be related 
to the formation of hemosiderin. Ferritinophagy involves 
ferritin interacting with the nuclear receptor coactivator 4 
protein, NCOA4, which directs the ferritin to lysosomes 
were it is degraded in an as yet undefined manner to release 
iron for use by the cell [96]. Whether degradative pathway 
are the only ones to exist in animals for release of iron from 
ferritins has not been established but if a reductive pathway 
exists that leaves the ferritin undamaged and able to func-
tion normally then the relative fluxes of iron through the dif-
ferent pathways will be important to determine.
Concluding remarks
In this review we have sought to discuss iron uptake into 
ferritins in a manner that illustrates the mechanistic diver-
sity that exists in this superfamily of proteins for what at 
first sight appears to be a common chemical event, the lay-
ing down of a polynuclear iron species in the central cavity 
of a common protein structure. The principle differences 
amongst our three ferritins we want to highlight are:
1. The ferroxidase centre of EcBFR is stable once formed 
and functions as a catalytic site for O2 reduction;
2. The apparently identical ferroxidase site of PaBFR is 
not stable and functions as a catalytic site for O2 reduc-
tion and a transit site for passage of Fe3+ ions into the 
central cavity;
3. PmFTN oxidises Fe2+ ions at its ferroxidase center 
extremely rapidly and only slowly builds up a core 
consistent with a major role in iron buffering rather 
than long-term iron storage.
Thus, just considering mechanistic details of three ferri-
tins shows that even when there is a considerable degree of 
structural similarity, which can even extend to the identity 
and conformation of inner-sphere ligands coordinating iron 
at a key functional site, mechanistic differences can be con-
siderable for aerobic uptake of iron ions. This leads on to the 
question of what the origin of the mechanistic differences can 
be, since it clearly can’t be simply the coordination sphere of 
the bound iron. Thus we have to consider outer-sphere effects. 
For example, do the coordinating ligands of different ferritins 
have similar hydrogen bonding interactions? As far as E. coli 
and P. aeruginosa BFRs are concerned the answer is yes [23, 
27], so this cannot account for the differing properties of their 
ferroxidase centers. So perhaps long-range effects result-
ing from electrostatic interactions and/or differing molecular 
dynamics modulate their chemical properties? However, to 
date a full consideration of these issues has not been reported, 
doubtless a reflection of the difficulty in actually carrying out 
these kinds of studies. What has been established thus far is 
that the electrostatic profiles of channels through the protein 
shells of different ferritins differ considerably [4, 16, 97, 98], 
and the dynamical properties of the channels of PaBFR [99] 
and the dynamical and electrostatic properties of frog fer-
ritin [8, 65, 100] influence the manner in which these pro-
teins accumulate iron. Similar studies with other ferritins are 
required to probe these aspects further.
We have suggested that the mechanistic differences 
within the ferritin superfamily reflect differing evolutionary 
pressures on amino acid sequences, and that these differing 
pressures are a consequence of different primary functions 
for different ferritins. Evidence to support this notion is not 
strong but it is clear that different ferritins do have different 
primary functions—not all have as their chief goal iron stor-
age as part of a general house-keeping function—and thus 
evolutionary pressures on them are expected to be different.
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